As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Kiplinger’s May 2026 Tax Letter highlights a shift in retirement plan policy that has been building since last summer. After ...

Maze Therapeutics is a U.S. biotech advancing clinical-stage precision medicines for renal and metabolic diseases.

Many retirees are advised to defer paying taxes on their investments until retirement. “So many advisors have helped clients ...

A stock that has returned 404% in a year, broken through dot-com era highs, and still attracted fresh institutional money is ...

Conservative MP Michael Chong is travelling to Taiwan this week in a self-described bid to assert Canadian sovereignty.

The Battery Atlanta’s Pennant Park has expanded its office roster with the addition of Chattanooga College and LAZ Parking, ...

Poet Technologies (NASDAQ: POET) stock recorded massive gains over the last week of trading. The photonics company's share ...

After the final school bell rings for the academic year, fewer high school students may head for jobs at fast-food chains and retail shops — some on their own volition and others due to an ongoing ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust ...

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...

WEST PALM BEACH, FL / ACCESS Newswire / May 17, 2026 / Management Believes This Moment Represents a Special Opportunity for Investors Worldwide to Discover and Participate in ELEKTROS Inc. as a Public ...